Published September 1, 2016
| Version v1
Patent
Open
METHODS AND COMPOSITIONS TO REDUCE LIVER DAMAGE ASSOCIATED WITH CONDITIONS OR THERAPIES THAT AFFECT THE IMMUNE SYSTEM
Contributors
Patent applicant:
Description
One side-effect arising from the use of antibodies against TNF receptor family members as therapeutics can be liver damage which precludes the completion of clinical trial. A novel LT-dependent pathway is described that mediates liver cell injury in several disease models.
Files
US20160250327.pdf
Files
(1.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:a177a9cdd6859116a718ed515340513c
|
1.0 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201615082898 A
- Patent number
- US 2016/0250327 A1
- Other
- oai:uchicago.tind.io:8729
Dates
- Patent filed
-
2016-03-28